Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Indolamid derivatives which possess glycogenphosphorylase inhibitory activity

Indolamid derivatives which possess glycogenphosphorylase inhibitory activity

US Patent 7138415 · Granted Nov 21, 2006

Estimated economic value: $48,549,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Heteroaryl compounds for the treatment of pain2025
Arginase inhibitors and methods of use thereof2025
Fused tricyclic compounds useful as anticancer agents2025
Arginase inhibitors and methods of use thereof2025
Arginase inhibitors and methods of use thereof2024
Imidazo[4,5-C]pyridine derived SSAO inhibitors2022
Substituted imidazo[4,5-c]pyridine compounds and compositions thereof2022
Arginase inhibitors and methods of use thereof2022
CXCR4 receptor antagonists2021
Imidazo[4,5-c]pyridine and pyrrolo[2,3-c]pyridine derivatives as SSAO inhibitors2021
Imidazo[4,5-c]pyridine and pyrrolo[2,3-c]pyridine derivatives as SSAO inhibitors2020
Compounds2020